NICE Upholds Advice Against NHS Use Of Orexigen’s Obesity Drug Mysimba

 
• By Ian Schofield
  
Rejected
NICE has confirmed its decision not to recommend Mysimba for NHS use
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet